MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma

被引：0

作者：

Seiko Hirono

Manabu Kawai

Ken-ichi Okada

Tsutomu Fujii

Masayuki Sho

Sohei Satoi

Ryosuke Amano

Hidetoshi Eguchi

Yuko Mataki

Masafumi Nakamura

Ippei Matsumoto

Hideo Baba

Masaji Tani

Yasunari Kawabata

Yuichi Nagakawa

Suguru Yamada

Yoshiaki Murakami

Toshio Shimokawa

Hiroki Yamaue

机构：

[1] Wakayama Medical University,Second Department of Surgery

[2] School of Medicine,Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences

[3] University of Toyama,Department of Surgery

[4] Nara Medical University,Department of Surgery

[5] Kansai Medical University,Department of Surgical Oncology

[6] Osaka City University,Department of Gastroenterological Surgery, Graduate School of Medicine

[7] Graduate School of Medicine,Department of Digestive Surgery, Breast and Thyroid Surgery

[8] Osaka University,Department of Surgery and Oncology, Graduate School of Medical Sciences

[9] Kagoshima University,Department of Surgery

[10] Kyushu University,Department of Gastroenterological Surgery, Graduate School of Life Science

[11] Kindai University Faculty of Medicine,Department of Surgery

[12] Kumamoto University,Department of Digestive and General Surgery

[13] Shiga University of Medical Science,Department of Gastrointestinal and Pediatric Surgery

[14] Shimane University Faculty of Medicine,Department of Gastroenterological Surgery

[15] Tokyo Medical University,Department of Surgery, Institute of Biomedical and Health Science

[16] Nagoya University,Clinical Study Support Center

[17] Graduate School of Medicine,undefined

[18] Hiroshima University,undefined

[19] Wakayama Medical University,undefined

[20] School of Medicine,undefined

来源：

Trials | / 19卷

关键词：

Mesenteric approach; Artery-first approach; Conventional approach; Pancreaticoduodenectomy; R0 resection; Pancreatic ductal adenocarcinoma; Resectable pancreatic cancer; Borderline resectable pancreatic cancer; Superior mesenteric artery;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Withholding vs. Continuing Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Before Non-cardiac Surgery in Older Patients: Study Protocol for a Multicenter Randomized Controlled Trial
Yang, Yu-fan
Zhu, Ya-juan
Long, Yu-qin
Liu, Hua-yue
Shan, Xi-sheng
Feng, Xiao-mei
Peng, Ke
Ji, Fu-hai
FRONTIERS IN MEDICINE, 2021, 8
[32] KG 4/2015: A randomized, controlled, multicenter, open-label phase III clinical trial of GV1001 with gemcitabine/capecitabine in previous untreated, eotaxin-high patients with advanced pancreatic ductal adenocarcinoma.
Jo, Jung Hyun
Kim, Yong-Tae
Choi, Ho Soon
Kim, Ho Gak
Lee, Hong Sik
Choi, Young Woo
Kim, Dong Uk
Lee, Kwang Hyuck
Kim, Eui Joo
Han, Jeong Ho
Lee, Seung Ok
Park, Chang-Hwan
Choi, Eun Kwang
Lee, Kyong Joo
Cho, Jae Yong
Lee, Woo Jin
Song, Si Young
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[33] ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.
Neoptolemos, John P.
Palmer, Dan
Ghaneh, Paula
Valle, Juan W.
Cunningham, David
Wadsley, Jonathan
Meyer, Tim
Anthoney, Alan
Glimelius, Bengt
Falk, Stephen
Segersvard, Ralf
Izbicki, Jakob R.
Middleton, Gary William
Ross, Paul J.
Wasan, Harpreet
Mcdonald, Alec
Crosby, Tom David Lewis
Psarelli, Eftychia Eirini
Hammel, Pascal
Buchler, Markus W.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18)
[34] Web-based cognitive-behavioral intervention for pain in pediatric acute recurrent and chronic pancreatitis: Protocol of a multicenter randomized controlled trial from the study of chronic pancreatitis, diabetes and pancreatic cancer (CPDPC)
Palermo, Tonya M.
Murray, Caitlin
Aalfs, Homer
Abu-El-Haija, Maisam
Barth, Bradley
Bellin, Melena D.
Ellery, Kate
Fishman, Douglas S.
Gariepy, Cheryl E.
Giefer, Matthew J.
Goday, Praveen
Gonska, Tanja
Heyman, Melvin B.
Husain, Sohail Z.
Lin, Tom K.
Liu, Quin Y.
Mascarenhas, Maria R.
Maqbool, Asim
McFerron, Brian
Morinville, Veronique D.
Nathan, Jaimie D.
Ooi, Chee Y.
Perito, Emily R.
Pohl, John F.
Schwarzenberg, Sarah Jane
Sellers, Zachary M.
Serrano, Jose
Shah, Uzma
Troendle, David
Zheng, Yuhua
Yuan, Ying
Lowe, Mark
Uc, Aliye
CONTEMPORARY CLINICAL TRIALS, 2020, 88
[35] Efficacy of INtensive Treatment vs. Standard Treatment of COmpound DanshEn Dripping Pills in Refractory Angina Patients With Incomplete Revascularization (INCODER Study): Study Protocol for a Multicenter, Double-Blind, Randomized Controlled, Superiority Trial
Wu, Zexuan
Xu, Danping
Wu, Zhen
Chen, Ailan
Liu, Lijuan
Ling, Li
Zhou, Yan
Liu, Duoduo
Liu, Yin
Dong, Yugang
Chen, Yili
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[36] Blood flow restriction Exercise in the perioperative setting to Prevent loss of muscle mass in patients with pancreatic, biliary tract, and liver cancer: study protocol for the PREV-Ex randomized controlled trial
Anandavadivelan P.
Cardinale D.
Blomhoff R.
Sunde B.
Lassen K.
Kleive D.
Sturesson C.
Gilg S.
Raastad T.
Mijwel S.
Trials, 25 (1)
[37] The CCTG PA.7 trial: A randomized phase II study of gemcitabine and nab-paclitaxel vs. gemcitabine, nab-paclitaxel, durvalumab, and tremelimumab as 1st line therapy in metastatic pancreatic ductal adenocarcinoma (PDAC).
Renouf, Daniel John
Kavan, Petr
Dhani, Neesha C.
Jonker, Derek J.
Wei, Alice Chia-chi
Hsu, Tina
Tang, Patricia A.
Graham, Barbara
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[38] Functional magnetic resonance imaging-based assessment of terlipressin vs. octreotide on renal function in cirrhotic patients with acute variceal bleeding (CHESS1903): study protocol of a multicenter randomized controlled trial
Yan, Xinwen
Shao, Ruoyang
Wang, Yuancheng
Mao, Xiaorong
Lei, Junqiang
Zhang, Liting
Zheng, Jianjun
Liu, Aimin
Zhao, Huimin
Gao, Fengxiao
Wang, Jitao
Li, Ping
Yao, Shengjuan
Xu, Ming
Xu, Jian
Liu, Dengxiang
Mi, Yuqiang
Gong, Xijun
Ye, Jun
Deng, Mingming
Dang, Tong
Ji, Jiansong
Shao, Chuxiao
Liu, Chao
Gu, Ye
Wu, Yunhong
Wang, Fengmei
Teng, Gaojun
Li, Xun
Qi, Xingshun
Ju, Shenghong
Qi, Xiaolong
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (20)
[39] The final analysis of a multicenter randomized controlled trial of gemcitabine (G) alone versus gemcitabine and S-1 combination therapy (GS) in patients with unresectable advanced pancreatic cancer (PC): GEMSAP study
Isayama, H.
Nakai, Y.
Sasaki, T.
Sasahira, N.
Hirano, K.
Tsujino, T.
Tada, M.
Omata, M.
Koike, K.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[40] Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)
Imai, Hiroo
Sakamoto, Yasuhiro
Takahashi, Shin
Shibata, Hiroyuki
Sato, Atsushi
Otsuka, Kazunori
Amagai, Kenji
Takahashi, Masanobu
Yamaguchi, Takuhiro
Ishioka, Chikashi
BMC CANCER, 2024, 24 (01)

← 1 2 3 4 5 →